https://www.selleckchem.com/pr....oducts/p5091-p005091
Parallelly combined with the current research trends and hot spots, we give the further improvement measures of microfluidic BBB chips.AML is a kind of hematological malignant tumor that urgently requires different treatment options in order to increase the cure rate and survival rate. Cytarabine (ara-C) is currently the main drug used to treat AML patients and is usually combined with different chemotherapeutic agents. However, due to resistance to ara-C, a new combination is needed to reduce ara-C resistance and improve treatmen
Like
Comment
Share
